Considering the crucial role inflammation plays in initiation and progression of thrombosis, various inflammatory biomarkers including CRP (C-reactive protein) and IL-6 (interleukin-6) have been reported to be valuable to predict DVT [6, 8, 9]. The gene discussed is IL6; the disease is deep vein thrombosis.